A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia.
about
Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remissionInterleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remissionLow-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720.Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission.Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia.New aspects of natural-killer-cell surveillance and therapy of cancer.Post-consolidation immunotherapy with histamine dihydrochloride and interleukin-2 in AML.The treatment of acute myeloid leukemia in first relapse: a comprehensive review of the literature.Targeted immunotherapy in acute myeloblastic leukemia: from animals to humans.Optimal therapy for adult patients with acute myeloid leukemia in first complete remission.Spontaneous remission of acute myeloid leukemia.Human CD80/IL2 lentivirus-transduced acute myeloid leukaemia (AML) cells promote natural killer (NK) cell activation and cytolytic activity: implications for a phase I clinical study.Transplantation for Childhood Acute Lymphoblastic Leukemia
P2860
Q24187927-AA711381-8D4A-4AAD-8781-8D77CBBA8F54Q24202630-EA475FBE-C189-4007-BDA4-731FC6DFE161Q33380148-B1EA44FC-E775-4017-A12B-3FEDB40C1EB7Q33380959-7BE34E7D-9743-4B64-965A-53763C1327CFQ33881750-2C16B67F-4B11-479B-BF51-0885EFA3F3F2Q34988265-23AFAECE-2C62-4D34-9C2E-BC6F715D7CE3Q34999124-5B284225-EA90-48A3-BA24-8B210F3C3AA9Q35103330-92D446B3-5329-4106-A656-EFC93B8F7512Q36124594-985A5EC8-3A28-4197-B739-20663659DEC7Q38208953-1E9008FE-E1E3-4F98-9C09-44271DA39FD3Q38256921-F604F02C-1199-416D-A3EC-4D2BD80D5E19Q47956596-55B42E95-2D75-4D15-9EE3-3F7CA245248BQ59094157-12840644-DA83-40ED-B2A3-DF23E3DF9D5B
P2860
A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
A phase II study of interleuki ...... or refractory acute leukemia.
@en
A phase II study of interleuki ...... or refractory acute leukemia.
@nl
type
label
A phase II study of interleuki ...... or refractory acute leukemia.
@en
A phase II study of interleuki ...... or refractory acute leukemia.
@nl
prefLabel
A phase II study of interleuki ...... or refractory acute leukemia.
@en
A phase II study of interleuki ...... or refractory acute leukemia.
@nl
P2093
P2860
P1433
P1476
A phase II study of interleuki ...... or refractory acute leukemia.
@en
P2093
Archimbaud E
Bouabdallah R
Brandely M
Maraninchi D
P2860
P304
P356
10.3109/10428199809059227
P577
1998-10-01T00:00:00Z